525 related articles for article (PubMed ID: 16815840)
1. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.
McMahon S; Charbonneau M; Grandmont S; Richard DE; Dubois CM
J Biol Chem; 2006 Aug; 281(34):24171-81. PubMed ID: 16815840
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
9. Periostin inhibits hypoxia-induced apoptosis in human periodontal ligament cells via TGF-β signaling.
Aukkarasongsup P; Haruyama N; Matsumoto T; Shiga M; Moriyama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):126-32. PubMed ID: 24129188
[TBL] [Abstract][Full Text] [Related]
10. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
Floyd ZE; Kilroy G; Wu X; Gimble JM
J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
Wu S; Nishiyama N; Kano MR; Morishita Y; Miyazono K; Itaka K; Chung UI; Kataoka K
Mol Ther; 2008 Jul; 16(7):1227-34. PubMed ID: 18500250
[TBL] [Abstract][Full Text] [Related]
14. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
15. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
17. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription.
Mak P; Chang C; Pursell B; Mercurio AM
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4708-13. PubMed ID: 23487784
[TBL] [Abstract][Full Text] [Related]
19. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing.
Wottawa M; Leisering P; Ahlen Mv; Schnelle M; Vogel S; Malz C; Bordoli MR; Camenisch G; Hesse A; Napp J; Alves F; Kristiansen G; Farhat K; Katschinski DM
Int J Cancer; 2013 Jun; 132(12):2787-98. PubMed ID: 23225569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
